Europe
Micronic has joined an elite group of manufacturers committed to product transparency and sustainable procurement.
labfolder GmbH from Berlin and the cubuslab GmbH from Karlsruhe are merging.
A new study has revealed the 25 most common diagnostic lab tests in the world, information that could be key for any jurisdiction looking to develop universal health coverage.
Objective responses, good safety and evidence of stimulation of the immune system observed under murlentamab (GM102) single agent and in combination with chemotherapy
Late-Breaking Clinical Trial Results and Updated Global SYMPLICITY Registry Data Demonstrate Long-Term Results of RDN for Uncontrolled Hypertension
Medigene AG announced that it entered into a Clinical Trial Agreement with the Leiden University Medical Center, the Netherlands, to conduct a Phase I clinical trial with Medigene’s T cell receptor modified T cell therapy MDG1021 targeting the HA-1 antigen.
Biopharma companies from across Europe share pipeline and strategy updates.
Synlogic is partnering with Roche to develop Synlogic’s SYNB1891 with Roche’s checkpoint inhibitor Tecentriq (atezolizumab) in advanced solid tumors.
The deal will grow Evotec’s business into a comprehensive offering including biologics in therapeutic areas such as oncology, CNS, pain, inflammation, metabolics and infectious diseases.
Biotech company Athera announce the closing of new share issue, raising in total 55 million SEK from current major shareholders including Industrifonden and Östersjöstiftelsen, together with new shareholders from the Sciety network of investors.
PRESS RELEASES